Background Multispecific antibodies represent a paradigm shift in biotherapeutics, moving beyond the traditional “one target, one antibody” model of monoclonal antibodies (mAbs). By enabling a single therapeutic molecule to bind two or more distinct antigens or epitopes, multispecific antibodies can engage complex biological networks with a level of precision unattainable by monospecific mAbs. Among these, […]
Drug Discovery
Background and Unmet Need Chimeric Antigen Receptor T-cell therapy or CAR-T is a type of cancer immunotherapy that utilizes a patient’s own T cells that are genetically modified to recognize and attack cancer cells. This form of treatment has become massively popular as a customized solution to cancer therapies. While a new therapeutic area, […]
Chemical collections and methods for rapid storage, retrieval and assay are vital for new drug discovery. LIMR Chemical Genomics Center’s (LCGC) large chemical collection covers a unique structural space not covered by other pharma or commercial libraries. LCGC has developed a variety of hardware and software solutions to enable efficient, low-cost drug screens directed to […]